These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7499115)

  • 1. Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients.
    Filov VA; Gershanovich ML; Danova LA; Ivin BA
    Invest New Drugs; 1995; 13(1):89-97. PubMed ID: 7499115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The results of a clinical study of the preparation hydrazine sulfate].
    Filov VA; Danova LA; Gershanovich ML; Ivin BA; Dement'eva NP; Breĭvis PV; Ragaĭshene VP; Kas'ianenko IV; Lisitsa AM; Mindlin SS
    Vopr Onkol; 1990; 36(6):721-6. PubMed ID: 2198698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
    Holsti LR; Hjelt AL
    Ann Med Intern Fenn; 1967; 56(3):119-24. PubMed ID: 5630600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of lymphomas with methyl-hydrazine (Ro 4-6467/1, MIH, "Natulanar")].
    de Oliveira HP; Atten MT
    Hospital (Rio J); 1966 Sep; 70(3):651-69. PubMed ID: 4867575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].
    Mathe G; Schneider M; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Concours Med; 1965 Jul; 87(27):4555-62. PubMed ID: 5841618
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of treatment of Hodgkin's disease and other lymphomas with a methylhydrazine, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride].
    Berumen L; Franco Guevara G
    Rev Med Hosp Gen (Mex); 1965 Mar; 28(3):175-82. PubMed ID: 5318927
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical study of hydrazine sulfate in advanced cancer patients.
    Spremulli E; Wampler GL; Regelson W
    Cancer Chemother Pharmacol; 1979; 3(2):121-4. PubMed ID: 389477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
    Spies SK; Snyman HW
    S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of a methylhydrazine derivative, Ro 4-6467, in Hodgkin's disease, in other malignant lymphomas and in leukemias].
    Kenis Y; Werli J; Hildebrand J; Tagnon HJ
    Eur J Cancer (1965); 1965 Jun; 1(1):33-40. PubMed ID: 5874785
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gluconeogenesis during therapy of experimental tumors with hydrazine sulfate].
    Filov VA; Burova TM
    Biull Eksp Biol Med; 1984 Jan; 97(1):73-4. PubMed ID: 6692028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
    Hansen MM; Hertz H; Videaek A
    Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
    Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
    Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
    Nissen I; Poulsen EH
    Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.
    Chlebowski RT; Bulcavage L; Grosvenor M; Oktay E; Block JB; Chlebowski JS; Ali I; Elashoff R
    J Clin Oncol; 1990 Jan; 8(1):9-15. PubMed ID: 1688616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
    Weick JK; Jones SE; Ryan DH
    Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
    Laetsch TW; DuBois SG; Mascarenhas L; Turpin B; Federman N; Albert CM; Nagasubramanian R; Davis JL; Rudzinski E; Feraco AM; Tuch BB; Ebata KT; Reynolds M; Smith S; Cruickshank S; Cox MC; Pappo AS; Hawkins DS
    Lancet Oncol; 2018 May; 19(5):705-714. PubMed ID: 29606586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
    De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testing of solid tumors in childhood for sensitivity against cytostatic agents using an autoradiographic in vitro method (short-term method) (author's transl)].
    Willnow U
    Arch Geschwulstforsch; 1979; 49(3):201-10. PubMed ID: 227341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.